Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis

American Journal of Pathology

Volumn 177, Issue 4, 2010, Pages 1638-1646

  Del Galdo, Francesco ^a,c   Shaw, M Alexander ^b,d   Jimenez, Sergio A ^a  

^a Thomas Jefferson University   (United Kingdom)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d Clinical Pharmacology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; COLLAGEN TYPE 1; ENOLASE; OSTEONECTIN; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEOME; RETICULOCALBIN 1; SECRETOME; TROPOMYOSIN; UNCLASSIFIED DRUG;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FIBROBLAST CULTURE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NEPHROGENIC SYSTEMIC FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

EID: 77957350375     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091095     Document Type: Article

References (53)

1. Varga J, Abraham D: Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007, 117:557-567 (Pubitemid 46348510)
2. Rosenbloom J, Castro SV, Jimenez SA: Fibrotic diseases: cellular and molecular mechanisms and novel therapies (Physiology in Medicine Series). Ann Intern Med 2010, 152:159-167
3. Gharaee-Kermani M, Phan SH: Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis. Curr Pharm Des 2005, 11:3943-3971 (Pubitemid 41637717)
4. Tsukada S, Parson CJ, Rieppe RA: Mechanisms of liver fibrosis. Clin Chim Acta 2006, 364:33-60
5. Cowper SE, Su LD, Bhawan J, Robin HS, LeBoit PE: Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001, 23:383-393
6. LeRoy EC: Connective tissue synthesis by scleroderma skin fibroblasts in cell culture. J Exp Med 1972, 135:1351-1362
7. Jelaska A, Arakawa M, Broketa G, Korn JH: Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts. Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts Arthritis Rheum 1996, 39:1338-1346
8. Jiménez SA, Feldman G, Bashey RI, Bienkowski R, Rosenbloom J: Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts. Biochem J. 1986, 237:837-843 (Pubitemid 16003787)
9. Jiménez SA, Saitta B: Alterations in the regulation of expression of the α 1(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma). Springer Semin Immunopathol 1999, 21:397-414
10. Kirk TZ, Mark ME, Chua CC, Chua BH, Mayes MD: Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 1995, 270:3423-3428
11. Steen VD, Medsger TA Jr: Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 2001, 44:2828-2835
12. Clements PJ, Hurwitz EL, Wong WK, Siebold JR, Mayes M, White B,Wigley F, Weisman M, Barr W, Moreland L, Medsger TA Jr, Steen VD, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Furst DE: Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum 2000, 43:2445-2454
13. Seibold JR, McCloskey DA: Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis. Curr Opin Rheumatol 1997, 9:571-575
14. Denton CP, Black CM, Abraham DJ: Mechanisms and consequences of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2006, 2:134-144
15. Doran JP, Veale DJ: Biomarkers in systemic sclerosis. Rheumatology (Oxford) 2008, 47:v36-v38
16. Hummers LK: Biomarkers of vascular disease in scleroderma. Rheumatology (Oxford) 2008, 47:v21-v22
17. Castro SV, Jimenez SA: Biomarkers in systemic sclerosis. Biomarkers Med 2010, 4:133-147
18. Sargent JL, Milano A, Connolly MK, Whitfield ML: Scleroderma gene expression and pathway signatures. Curr Rheumatol Rep 2008, 10:205-211
19. Farina G. Lafyatis D. Lemaire R, Lafyatis R: A four-gene biomarker predicts skin disease in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 2010, 62:580-588
20. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, Silman AJ, Allegar N, Varga J, Massa M, Wigley FM, Ingenito F, Weisman M, White B, Martin RW, McCloskey D, Moreland LW, Mayes M, Lally EV, Unanue M, Collier DH, Weiner S, Weinstein A, Medsger TA Jr, Andrews B, Dixon M, Furst DE: Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993, 20:1892-1896 (Pubitemid 24031593)
21. Jiménez SA, Artlett CM, Sandorfi N, Derk C, Latinis K, Sawaya H, Haddad R, Shanahan JC: Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 2004, 50:2660-2666 (Pubitemid 39062729)
22. Mendoza FA, Artlett CM, Sandorfi N, Latinis K, Piera-Velazquez S, Jiménez SA: Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 2006, 35:238-249 (Pubitemid 43185214)
23. Grobner T, Prischl FC: Gadolinium and nephrogenic systemic fibrosis. Kidney Int 2007, 72:260-264
24. Piera-Velazquez S, Louneva N, Wermuth PJ, Fertala J, Del Galdo F, Jimenez SA. Persistent activation of dermal fibroblasts from patients with gadolinium-associated Nephrogenic Systemic Fibrosis. Ann Rheum Dis 2010, DOI: 10.1136/ard.2009.127761
25. Edward M, Fitzgerald L, Thind C, Leman J, Burden AD: Cutaneous mucinosis associated with dermatomyositis and nephrogenic fibrosing dermopathy: fibroblast hyaluronan synthesis and the effect of patient serum. Br J Dermatol 2007, 156:473-479 (Pubitemid 46253930)
26. Subcommittee for Scleroderma Criteria of the American Rheumatism Association: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590
27. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205 (Pubitemid 18073738)
28. Sharma K, Lee S, Han S, Francos B, McCue P, Wassell R, Shaw MA, RamachandraRao SP: Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 2005, 5:2648-2655 (Pubitemid 40966492)
29. Ramachandra Rao SP, Wassell R, Shaw MA, Sharma K: Profiling of human mesangial cell subproteomes reveals a role for calmodulin in glucose uptake. Am J Physiol Renal Physiol 2007, 292:F1182-F1189
30. Karp NA, Kreil DP, Lilley KS: Determining a significant change in protein expression with DeCyder™ during a pair-wise comparison using two-dimensional difference gel electrophoresis. Proteomics 2004, 4:1421-1432
31. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, Apweiler R, Haab BB, Simpson RJ, Eddes JS, Kapp EA, Moritz RL, Chan DW, Rai AJ, Admon A, Aebersold R, Eng J, Hancock WS, Hefta SA, Meyer H, Paik YK, Yoo JS, Ping P, Pounds J, Adkins J, Qian X, Wang R, Wasinger V, Wu CY, Zhao X, Zeng R, Archakov A, Tsugita A, Beer I, Pandey A, Pisano M, Andrews P, Tammen H, Speicher DW, Hanash SM: Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 2005, 5:3226-3245
32. 2+-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett 2000, 466:11-18
33. Vorum H, Hager H, Christensen BM, Nielsen S, Honoré B: Human calumenin localizes to the secretory pathway and is secreted to the medium. Exp Cell Res 1999, 248:473-481
34. Fukuda T, Oyamada H, Isshiki T, Maeda M, Kusakabe T, Hozumi A, Yamaguchi T, Igarashi T, Hasegawa H, Seidoh T, Suzuki T: Distribution and variable expression of secretory pathway protein reticulocalbin in normal human organs and non-neoplastic pathological conditions. J Histochem Cytochem 2007, 55:335-345
35. Verrecchia F, Laboureau J, Verola O, Roos N, Porcher R, Bruneval P, Ertault M, Tiev K, Michel L, Mauviel A, Farge D: Skin involvement in scleroderma - where histological and clinical scores meet. Rheumatology (Oxford) 2007, 46:833-841
36. Davies CA, Jeziorska M, Freemont AJ, Herrick AL: Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis. Rheumatology (Oxford) 2006, 45:1349-1355
37. Macko RF, Gelber AC, Young BA, Lowitt MH, White B, Wigley FM, Goldblum SE: Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation. J Rheumatol 2002, 29:2565-2570
38. LeRoy EC: Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. J Clin Invest 1974, 54:880-889
39. Buckingham RB, Prince RK, Rodnan GP, Taylor F: Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma). J Lab Clin Med 1978, 92:5-21
40. Hitraya EG, Jiménez SA: Transcriptional activation of the α(I) procollagen gene in systemic sclerosis dermal fibroblasts: role of intronic sequences. Arthritis Rheum 1996, 39:1347-1354
41. Wang Y, Fan PS, Kahaleh B: Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum 2006, 54:2271-2279
42. Kulasingam V, Diamandis EP: Tissue culture-based breast cancer biomarker discovery platform. Int J Cancer 2008, 123:2007-2012
43. Sardana G, Marshall J, Diamandis EP: Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium. Clin Chem 2007, 53:429-437
44. Rottoli P, Magi B, Perari MG, Liberatori S, Nikiforakis N, Bargagli E, Cianti R, Bini L, Pallini V: Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005, 5:1423-1430
45. Bogatkevich GS, Ludwicka-Bradley A, Singleton CB, Bethard JR, Silver RM: Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration. Am J Physiol Lung Cell Mol Physiol 2008, 295:L603-L611
46. Aden N, Shiwen X, Aden D, Black C, Nuttall A, Denton CP, Leask A, Abraham D, Stratton R: Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer. Rheumatology (Oxford) 2008, 47:1754-1760
47. Mintz M, Vanderver A, Brown KJ, Lin J, Wang Z, Kaneski C, Schiffmann R, Nagaraju K, Hoffman EP, Hathout Y: Time series proteome profiling to study endoplasmic reticulum stress response. J Proteome Res 2008, 7:2435-2444
48. Bassuk JA, Berg RA: Protein disulphide isomerase, a multifunctional endoplasmic reticulum protein. Matrix 1989, 9:244-258
49. Kellokumpu S, Suokas M, Risteli L, Myllylä R: Protein disulfide isomerase and newly synthesized procollagen chains form higher-order structures in the lumen of the endoplasmic reticulum. J Biol Chem 1997, 272:2770-2777
50. Wilson R, Lees JF, Bulleid NJ: Protein disulfide isomerase acts as a molecular chaperone during the assembly of procollagen. J Biol Chem 1998, 273:9637-9643
51. Ko MK, Key EP: PDI-mediated ER retention and proteasomal degradation of procollagen I in corneal endothelial cells. Exp Cell Res 2004, 295:25-35
52. Guiducci S, Distler JHW, Jüngel A, Huscher C, Huber LC, Michel BA, Gay RE, Pisetsky DS, Gay S, Matucci-Cerinic M, Distler O: The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum 2008, 58:2845-2853
53. Jüngel A, Distler O, Schulze-Horsel U, Huber LC, Ha HR, Simmen B, Kalden JR, Pisetsky DS, Gay S, Distler JH: Microparticles stimulate the synthesis of prostaglandin E2 via induction of cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Arthritis Rheum 2007, 56:3564-3574